Literature DB >> 15662969

Transduction of human glial and neuronal tumor cells with different lentivirus vector pseudotypes.

Sabine Steffens1, Jessica Tebbets, Christof M Kramm, Dirk Lindemann, Alan Flake, Miguel Sena-Esteves.   

Abstract

Lentiviral vectors have proven to be valuable tools for in vitro and in vivo gene delivery because they can transduce dividing and non-dividing cells efficiently, and mediate long-term gene expression. Pseudotyping of lentiviral vectors with envelope proteins other than VSV-G has resulted in enhanced transduction of certain cell types and tissues. In order to improve lentiviral vector-based gene therapy for peripheral neuroectodermal and brain tumors, we compared the efficiency of eight different lentivirus pseudotypes in transducing neuronal and glial tumor cell lines. Here, lentiviral vectors pseudotyped with the envelopes from human foamy virus, rabies, Mokola or amphotropic murine leukemia virus displayed the highest transduction efficiency in neuroblastomas, whereas pseudotyping with the lymphocytic choriomeningitis virus glycoprotein from strain Armstrong 53b resulted in the highest transduction efficiency in gliomas.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15662969     DOI: 10.1007/s11060-004-6046-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  27 in total

1.  Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

Authors:  R Zufferey; J E Donello; D Trono; T J Hope
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Gene transfer to hepatocellular carcinoma: transduction efficacy and transgene expression kinetics by using retroviral and lentiviral vectors.

Authors:  R Gerolami; R Uch; F Jordier; S Chapel; C Bagnis; C Bréchot; P Mannoni
Journal:  Cancer Gene Ther       Date:  2000-09       Impact factor: 5.987

3.  Organ distribution of gene expression after intravenous infusion of targeted and untargeted lentiviral vectors.

Authors:  K W Peng; L Pham; H Ye; R Zufferey; D Trono; F L Cosset; S J Russell
Journal:  Gene Ther       Date:  2001-10       Impact factor: 5.250

Review 4.  Lentiviruses as gene transfer agents for delivery to non-dividing cells.

Authors:  L Naldini
Journal:  Curr Opin Biotechnol       Date:  1998-10       Impact factor: 9.740

5.  Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins.

Authors:  Deborah J Watson; Gary P Kobinger; Marco A Passini; James M Wilson; John H Wolfe
Journal:  Mol Ther       Date:  2002-05       Impact factor: 11.454

6.  Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins.

Authors:  N Desmaris; A Bosch; C Salaün; C Petit; M C Prévost; N Tordo; P Perrin; O Schwartz; H de Rocquigny; J M Heard
Journal:  Mol Ther       Date:  2001-08       Impact factor: 11.454

7.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles.

Authors:  J Reiser; G Harmison; S Kluepfel-Stahl; R O Brady; S Karlsson; M Schubert
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

8.  Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes.

Authors:  Tippi C MacKenzie; Gary P Kobinger; Neeltje A Kootstra; Antoneta Radu; Miguel Sena-Esteves; Sarah Bouchard; James M Wilson; Inder M Verma; Alan W Flake
Journal:  Mol Ther       Date:  2002-09       Impact factor: 11.454

Review 9.  Comparison of replication-selective, oncolytic viruses for the treatment of human cancers.

Authors:  Oliver Wildner
Journal:  Curr Opin Mol Ther       Date:  2003-08

10.  Determinants of foamy virus envelope glycoprotein mediated resistance to superinfection.

Authors:  Angelika Berg; Thomas Pietschmann; Axel Rethwilm; Dirk Lindemann
Journal:  Virology       Date:  2003-09-15       Impact factor: 3.616

View more
  6 in total

Review 1.  Altering the tropism of lentiviral vectors through pseudotyping.

Authors:  James Cronin; Xian-Yang Zhang; Jakob Reiser
Journal:  Curr Gene Ther       Date:  2005-08       Impact factor: 4.391

2.  Cell surface molecules involved in infection mediated by lymphocytic choriomeningitis virus glycoprotein.

Authors:  Masayuki Shimojima; Yoshihiro Kawaoka
Journal:  J Vet Med Sci       Date:  2012-06-01       Impact factor: 1.267

3.  Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.

Authors:  Yue Peng; Fan-ching Lin; Paulo H Verardi; Leslie A Jones; Tilahun D Yilma
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

4.  Foamy virus as a gene transfer vector to the central nervous system.

Authors:  A V Caprariello; R H Miller; S M Selkirk
Journal:  Gene Ther       Date:  2008-12-04       Impact factor: 5.250

5.  Coronavirus genetically redirected to the epidermal growth factor receptor exhibits effective antitumor activity against a malignant glioblastoma.

Authors:  Monique H Verheije; Martine L M Lamfers; Thomas Würdinger; Guy C M Grinwis; Winald R Gerritsen; Victor W van Beusechem; Peter J M Rottier
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

Review 6.  Oncolytic viruses in cancer therapy.

Authors:  Markus J V Vähä-Koskela; Jari E Heikkilä; Ari E Hinkkanen
Journal:  Cancer Lett       Date:  2007-03-23       Impact factor: 8.679

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.